1. Farnesyl transferase inhibitors: a major breakthrough in anticancer therapy? Naples, 12 April 2002
2. Njoroge, F. G.; Girijavallabhan, V. M.Curr. Med.Chem. Immunol., Endocr. Metab. Agents2001,1, 185−198. Liu, M.; Bryant, M. S.; Chen, J.; Lee, S.; Yaremko, B.; Lipari, P.; Malkowski, M.; Ferrari, E.; Nielsen, L.; Prioli, N.; Dell, J.; Sinha, D.; Syed, J.; Korfmacher, W. A.; Nomeir, A. A.; Lin, C.C.; Wang, L.; Taveras, A. G.; Doll, R. J.; Njoroge, F. G.; Mallams, A. K.; Remiszewski, S.; Catino, J. J.; Girijavallabhan, V. M.; Kirschmeier, P.; Bishop, W. R.Cancer Res.1998,58, 4947−4956.
3. Farnesyl Protein Transferase Inhibition: A Novel Approach to Anti-tumor
4. Highly Regioselective Nitration Reactions Provide a Versatile Method of Functionalizing Benzocycloheptapyridine Tricyclic Ring Systems: Application toward Preparation of Nanomolar Inhibitors of Farnesyl Protein Transferase